Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Learn about the various fees that may come with cash back credit cards. Equip yourself with this knowledge before applying.
22,981 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Oracle’s stock has fallen from its AI-redemption peak as management bets heavily on data-center compute. Analysts are...
Meta’s latest move signals a serious push into cloud services. This article breaks down what Mark Zuckerberg's Meta l...
When a legendary investor shifts big positions, traders sit up. This piece breaks down what it could mean that billio...
A high-profile investor sends a pointed message about Whirlpool’s strategy. This article explains what the billionair...
When a stimulus move hits a niche chip maker like Tower Semiconductor, investors ask what really caused it. This arti...
Mega-cap tech names are offering ballast as markets wobble, but the rally is fragile and depends on earnings momentum...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Rivian faces a pivotal year as it scales both consumer and commercial EVs amid market volatility. This rivian stock p...
Deciding when to start Social Security can dramatically change retirement income. Learn how to assess your situation ...
A clear, practical look at Expedia's Q1 2026 earnings, what drove results, and what to watch next. Learn the segments...
Strategy unveils a private repurchase of roughly $1.5 billion in convertible notes, funded by cash, ATM proceeds, and...